Stuttgart - Delayed Quote EUR
Biomark Diagnostics Inc (20B.SG)
0.1550
-0.0010
(-0.64%)
As of 8:12:49 AM GMT+2. Market Open.
Loading Chart for 20B.SG
- Previous Close
0.1560 - Open
0.1550 - Bid 0.1540 x 500000
- Ask 0.1840 x 500000
- Day's Range
0.1550 - 0.1550 - 52 Week Range
0.0985 - 0.1830 - Volume
0 - Avg. Volume
161 - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: 20B.SG
View MorePerformance Overview: 20B.SG
Trailing total returns as of 5/12/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
20B.SG
42.20%
S&P/TSX Composite index (^GSPTSE)
3.82%
1-Year Return
20B.SG
15.30%
S&P/TSX Composite index (^GSPTSE)
14.58%
3-Year Return
20B.SG
4.03%
S&P/TSX Composite index (^GSPTSE)
29.76%
5-Year Return
20B.SG
109.46%
S&P/TSX Composite index (^GSPTSE)
71.77%
Compare To: 20B.SG
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 20B.SG
View MoreValuation Measures
As of 5/7/2025
Market Cap
16.29M
Enterprise Value
16.59M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
131.39
Price/Book (mrq)
--
Enterprise Value/Revenue
167.10
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--